Clinical Adjudication of Hemodialysis Catheter-Related Bloodstream Infections: Findings from the REDUCCTION Trial.

Jayson Catiwa Martin P Gallagher Benjamin Talbot Peter G Kerr David J Semple Matthew A Roberts Kevan R Polkinghorne Nicholas A GrayGirish TalaulikarAlan CassSradha S Kotwalnull null

Published in: Kidney360 (2024)

There was a substantial level of concordance in overall and service-level reporting of confirmed HD-CRBSI. A standardized endpoint definition of HD-CRBSI resulted in comparable hemodialysis catheter infection rates in Australian and New Zealand kidney services. Consistent endpoint definition could enable reliable benchmarking outside clinical trials without the need for independent clinical adjudication.

Keyphrases

clinical trial
healthcare
peritoneal dialysis
end stage renal disease
chronic kidney disease
primary care
phase ii
phase iii
adverse drug
open label